# Levo Phencynonate Hydrochloride for the Prevention of Seasickness

> **NCT02241629** · PHASE2 · COMPLETED · sponsor: **Sihuan Pharmaceutical Holdings Group Ltd.** · enrollment: 180 (actual)

## Conditions studied

- Motion Sickness

## Interventions

- **DRUG:** placebo
- **DRUG:** levo phencynonate hydrochloride

## Key facts

- **NCT ID:** NCT02241629
- **Lead sponsor:** Sihuan Pharmaceutical Holdings Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2015-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02241629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02241629, "Levo Phencynonate Hydrochloride for the Prevention of Seasickness". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02241629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*